Cargando…
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
Breast cancer is the most common form of cancer in women, contributing to high rates of morbidity and mortality owing to the ability of these tumors to metastasize via the vascular system even in the early stages of progression. While ultrasonography and mammography have enabled the more reliable de...
Autores principales: | Qiu, Jie, Qian, Da, Jiang, Yuancong, Meng, Liwei, Huang, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628786/ https://www.ncbi.nlm.nih.gov/pubmed/37941557 http://dx.doi.org/10.3389/fonc.2023.1288077 |
Ejemplares similares
-
Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
por: Wan, Lingling, et al.
Publicado: (2021) -
Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
por: Kan, Chin Fung Kelvin, et al.
Publicado: (2021) -
Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022) -
Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer
por: Qian, Da, et al.
Publicado: (2021) -
Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021)